418 related articles for article (PubMed ID: 18795673)
1. A short course of preoperative radiotherapy improves prognosis of operable rectal carcinoma: a case control study.
Penopoulos V; Handolias M; Avgerinos A; Maris T; Ilias T; Issopoulos N; Christianopoulos G; Betsis D; Vrettou E; Kitis G; Pistevou K
Hepatogastroenterology; 2008; 55(85):1280-7. PubMed ID: 18795673
[TBL] [Abstract][Full Text] [Related]
2. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
3. [A comparative study in rectal adenocarcinoma: preoperative or postoperative radiotherapy].
Martín de Vidales C; Cerezo L; Vázquez de la Torre ML; Zapatero A; Del Cerro E; Pinar B; Domínguez P; Pérez Torrubia A
Rev Esp Enferm Dig; 1995 Mar; 87(3):199-204. PubMed ID: 7742048
[TBL] [Abstract][Full Text] [Related]
4. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
5. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
Klenova A; Georgiev R; Kurtev P; Kurteva G
J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
[TBL] [Abstract][Full Text] [Related]
6. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
[TBL] [Abstract][Full Text] [Related]
8. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
9. Short course continuous, hyperfractionated, accelerated radiation therapy (CHART) as preoperative treatment for rectal cancer.
Brooks S; Glynne-Jones R; Novell R; Harrison M; Brown K; Makris A
Acta Oncol; 2006; 45(8):1079-85. PubMed ID: 17118843
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Swedish Rectal Cancer Trial.
Eur J Surg; 1996 May; 162(5):397-402. PubMed ID: 8781922
[TBL] [Abstract][Full Text] [Related]
12. Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II).
Widder J; Herbst F; Dobrowsky W; Schmid R; Pokrajac B; Jech B; Chiari C; Stift A; Maier A; Karner-Hanusch J; Teleky B; Wrba F; Jakesz R; Poetter R
Br J Cancer; 2005 Apr; 92(7):1209-14. PubMed ID: 15785745
[TBL] [Abstract][Full Text] [Related]
13. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638
[TBL] [Abstract][Full Text] [Related]
15. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of long- term efficacy between preoperative radiotherapy or radiochemotherapy followed by lower-anterior resection and Miles abdominoperineal resection in patients with low rectal cancer].
Liu JD; Du TH; Liu LY; Wei WJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jul; 8(4):297-300. PubMed ID: 16167244
[TBL] [Abstract][Full Text] [Related]
17. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
18. [Brief preoperative radiotherapy reduces local recurrences and improves survival in rectal cancer].
Peretz T; Weshler Z; Goldberg Y; Durst AL; Freund HR
Harefuah; 2000 Jan; 138(2):96-9, 175. PubMed ID: 10883067
[TBL] [Abstract][Full Text] [Related]
19. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
Klenova A; Parvanova V; Georgiev R; Gesheva N
J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
[TBL] [Abstract][Full Text] [Related]
20. Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision?
Suh KW; Kim BW; Chun M; Lim HY
Hepatogastroenterology; 2002; 49(44):399-403. PubMed ID: 11995460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]